Director Scott M Rocklage sold $9.0M of Aprea Therapeutics, Inc.

Sold$8,963,250

$35.15Price

255,000Shares

−74%Stake

What APRE did after the filing

Prices for APRE after this filing aren't in yet.

Traded Tue, May 19. Filed Thu, May 21, 5:32 PM ET, after the close. Not investment advice.